Bevacizumab/Irinotecan

DRUG2 trials

Sponsors

Clinical Research Center for Solid Tumor, Korea, CytoVac A/S

Conditions

AstrocytomaGlioblastomaGlioblastoma Multiforme

Phase 2

A Study to Evaluate the Efficacy of Bevacizumab Plus Irinotecan in Recurrent Gliomas

CompletedNCT00921167

Clinical Research Center for Solid Tumor, KoreaAstrocytoma, Glioblastoma

Start: 2009-06-30End: 2013-12-31Target: 32Updated: 2013-12-04

Randomized Phase 2 Study to Investigate Efficacy of ALECSAT in Patients With GBM Measured Compared to Avastin/Irinotecan

TerminatedNCT02060955

CytoVac A/SGlioblastoma Multiforme

Start: 2014-02-28End: 2015-07-31Updated: 2016-06-06